Skip to content

The clinical trail of insomnia treated with Tianmeng capsule

The clinical trail of insomnia treated with Tianmeng capsule

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000856
Enrollment
Unknown
Registered
2010-04-20
Start date
2010-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Test group:Tianmeng capsule
control:Tianmeng capsule simulation agent

Sponsors

institute of Basical clinical Medcine, china Academy of chinese Medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria for insomnia medicine; 2. comply with the spirit of the preparation of the WHO classification and behavioral disorders (ICD-10) diagnostic criteria for non-organic insomnia; 3. SPIEGEL test score >=12 points were; 4. The Athens Insomnia Scale >=6 points were; 5. age 18 ~65 years old; 6. the subjects voluntarily participated in clinical trials, and signed informed consent given.

Exclusion criteria

Exclusion criteria: 1. Any systemic disease such as pain, fever, cough, surgery and distraction caused by the external environment; 2. pregnancy or breast-feeding women, those who are allergic to this drug; 3. associated with cardiovascular, lung, liver, kidney and hematopoietic system such as severe primary diseases, mental illness.

Design outcomes

Primary

MeasureTime frame
Insomnia point;

Secondary

MeasureTime frame
Symptom score in the TCM;

Countries

China

Contacts

Public ContactZhong Wang
zhonw@sina.com+86 13601315446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026